CIZZLE BIOTECHNOLOGY HOLDINGS PLC
CIZ | IL
Overview
Corporate Details
- ISIN(s):
- GB00BNG2VN02
- LEI:
- 213800G3OS3SA2J1Y358
- Country:
- United Kingdom
- Address:
- 6TH FLOOR, 60 GRACECHURCH STREET, EC3V 0HR LONDON
- Website:
- https://cizzlebiotechnology.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Cizzle Biotechnology Holdings PLC develops diagnostic tools for early detection of lung cancer.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-08 10:40 |
Annual Report
Annual Report for the year ended 31 December 2024
|
English | 332.7 KB | |
| 2025-06-06 12:00 |
Report Publication Announcement
Notice of AGM
|
English | 11.4 KB | |
| 2025-05-28 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 51.1 KB | |
| 2025-03-25 08:00 |
Board/Management Information
Appointment of Non-Executive Director
|
English | 15.7 KB | |
| 2025-01-02 08:00 |
Board/Management Information
Appointment of Professor Dawn Coverley as CSO
|
English | 17.8 KB | |
| 2024-12-16 08:00 |
Business and Financial Review
Update on Strategic Partnership in North America
|
English | 23.8 KB | |
| 2024-10-21 08:00 |
Transaction in Own Shares
Execution of Agreement for North America
|
English | 25.9 KB | |
| 2024-10-03 14:12 |
Regulatory News Service
Update on Licensing and Partnership Agreement
|
English | 10.6 KB | |
| 2024-09-30 08:00 |
Earnings Release
Interim Results
|
English | 208.3 KB | |
| 2024-09-16 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 37.5 KB | |
| 2024-09-09 08:00 |
Regulatory News Service
Collaboration with Moffitt Cancer Center
|
English | 25.0 KB | |
| 2024-07-25 08:00 |
Regulatory News Service
Update on Strategic Partnership in North America
|
English | 15.2 KB | |
| 2024-07-18 08:00 |
Inside Information Statement
Manufacturing Agreement with BBI Solutions
|
English | 21.1 KB | |
| 2024-07-09 08:00 |
Regulatory News Service
Issue of Share Options in Lieu of Consultancy Fees
|
English | 14.0 KB | |
| 2024-06-24 13:42 |
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
|
English | 24.7 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Herantis Pharma Oyj | Finland | HRTIS | |
| Hiron-Trade Investments & Industrial Buildings Ltd. | Israel | HRON | ||
|
Human Stem Cells Institute PJSC | Russian Federation | ISKJ | |
|
Human Xtensions Ltd. | Israel | HUMX | |
|
Hybrigenics SA | France | ALHYG | |
|
Hyloris Pharmaceuticals SA | Belgium | HYL | |
|
Ikonisys S.A. | France | ALIKO | |
|
IMCB PJSC | Russian Federation | GEMA | |
|
Immunic AG | United States of America | IMUX | |
| Incanthera plc | United Kingdom | N/A |